.After antibody-drug conjugate (ADC) specialist Seagen was actually marketed to Pfizer in 2015 for a...
.On the heels of a stage 3 succeed that neglected to impress financiers, Ironwood Pharmaceuticals is...
.Do not quit Monte Rosa Therapeutics now. The Boston-based biotech is actually having a ball after a...
.Invite to recently's Chutes & Ladders, our summary of substantial management hirings, firings as...
.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the positi...
.AbbVie has come back to the source of its own antipsychotic goliath Vraylar looking for yet another...
.GenSight Biologics is actually weeks away from lacking cash. Again. The biotech just has enough cas...
.Monopar Rehabs is actually recuperating a medicine from the scrap heap of AstraZeneca's rare diseas...
.With brand new information out on Arcus Biosciences' experimental HIF-2a prevention, one team of an...
.After forming a genetics therapy alliance with Dyno Therapeutics in 2020, Roche is actually back fo...